{
     "PMID": "10471378",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "19991007",
     "LR": "20131121",
     "IS": "0006-291X (Print) 0006-291X (Linking)",
     "VI": "262",
     "IP": "3",
     "DP": "1999 Sep 7",
     "TI": "6-Methyl-3'-bromoflavone, a high-affinity ligand for the benzodiazepine binding site of the GABA(A) receptor with some antagonistic properties.",
     "PG": "643-6",
     "AB": "6-Methyl-3'-bromoflavone inhibited [(3)H]flunitrazepam binding to the benzodiazepine binding site of the GABA(A) receptor (BDZ-bs) with Ki values between 10 and 50 nM in different brain regions. The GABA ratio of 1.03 for [(3)H]flunitrazepam binding to cerebral cortex, 0.76 for cerebellum, 0.7 for hippocampus, 0.7 for striatum, and 0.8 for spinal cord indicated an antagonistic or weak inverse agonistic profile of 6-methyl-3'-bromoflavone on BDZ-bs. Unlike classical benzodiazepines, it had no anticonvulsant, anxiolytic, myorelaxant, sedative, amnestic or motor incoordination effects. However, it antagonized the muscle relaxant, the sedative effect, and the changes in locomotor activity induced by diazepam. Taken together, these findings suggest that 6-methyl-3'-bromoflavone has an antagonistic profile on the BDZ-bs.",
     "CI": [
          "Copyright 1999 Academic Press."
     ],
     "FAU": [
          "Viola, H",
          "Marder, M",
          "Nunez, J",
          "Izquierdo, L",
          "Wasowski, C",
          "Wolfman, C",
          "Ardenghi, P",
          "Barros, D",
          "Medina, J H",
          "Paladini, A C"
     ],
     "AU": [
          "Viola H",
          "Marder M",
          "Nunez J",
          "Izquierdo L",
          "Wasowski C",
          "Wolfman C",
          "Ardenghi P",
          "Barros D",
          "Medina JH",
          "Paladini AC"
     ],
     "AD": "Facultad de Medicina, Instituto de Biologia Celular, Paraguay 2155 (1121), Buenos Aires, Argentina.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "United States",
     "TA": "Biochem Biophys Res Commun",
     "JT": "Biochemical and biophysical research communications",
     "JID": "0372516",
     "RN": [
          "0 (6-methyl-3'-bromoflavone)",
          "0 (Flavonoids)",
          "0 (GABA Antagonists)",
          "0 (GABA-A Receptor Antagonists)",
          "0 (Ligands)",
          "0 (Receptors, GABA-A)",
          "620X0222FQ (Flunitrazepam)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Binding Sites",
          "Binding, Competitive",
          "Brain/*metabolism",
          "Cerebellum/metabolism",
          "Cerebral Cortex/metabolism",
          "Corpus Striatum/metabolism",
          "Flavonoids/chemical synthesis/chemistry/*pharmacology",
          "Flunitrazepam/pharmacokinetics",
          "GABA Antagonists/*pharmacology",
          "GABA-A Receptor Antagonists",
          "Hippocampus/metabolism",
          "Intracellular Membranes/metabolism",
          "Kinetics",
          "Ligands",
          "Male",
          "Mice",
          "Receptors, GABA-A/*metabolism",
          "Spinal Cord/*metabolism",
          "Synaptosomes/*metabolism"
     ],
     "EDAT": "1999/09/02 00:00",
     "MHDA": "1999/09/02 00:01",
     "CRDT": [
          "1999/09/02 00:00"
     ],
     "PHST": [
          "1999/09/02 00:00 [pubmed]",
          "1999/09/02 00:01 [medline]",
          "1999/09/02 00:00 [entrez]"
     ],
     "AID": [
          "10.1006/bbrc.1999.1273 [doi]",
          "S0006-291X(99)91273-1 [pii]"
     ],
     "PST": "ppublish",
     "SO": "Biochem Biophys Res Commun. 1999 Sep 7;262(3):643-6. doi: 10.1006/bbrc.1999.1273.",
     "term": "hippocampus"
}